Welcome, Guest. Please login or register.
August 20, 2017, 11:20:27 AM

Login with username, password and session length


Members
  • Total Members: 5402
  • Latest: garyc93
Stats
  • Total Posts: 49921
  • Total Topics: 3920
  • Online Today: 49
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 AM)
Users Online
Users: 1
Guests: 29
Total: 30

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: In the Battle of the Statins, Which Is Better for People With HIV?  (Read 546 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 372
    • Hep Mag
In a major head-to-head study comparing the efficacy of statin medications among people living with HIV, Livalo (pitavastatin) proved superior to Pravachol (pravastatin) on numerous measures, MedPage Today reports.

Publishing their findings in The Lancet HIV, researchers from the randomized, double-blind, active-controlled, Phase IV INTREPID study recruited people with well-treated HIV between the ages of 18 and 70 who had been taking antiretroviral (ARV) treatment for at least six months and had dyslipidemia (abnormally elevated cholesterol or fats in the blood—a condition, researchers said, that may occur in up to 80 percent of people living with HIV).

Read more...
https://www.hepmag.com/article/battle-statins-better-people-hiv

 


© 2017 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.